A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

Ilana Chefetz, Raoul Heller, Assimina Galli-Tsinopoulou, Gabriele Richard, Bernd Wollnik, Margarita Indelman, Friederike Koerber, Orit Topaz, Reuven Bergman, Eli Sprecher, Eckhard Schoenau

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

Hyperphosphatemic Familial Tumoral Calcinosis (HFTC; MIM211900) is a rare autosomal recessive disorder characterized by the progressive deposition of calcified masses in cutaneous and subcutaneous tissues, associated with elevated circulating levels of phosphate. The disease was initially found to result from mutations in GALNT3 encoding a glycosyltransferase. However, more recently, the S71G missense mutation in FGF23, encoding a potent phosphaturic protein, was identified in two families. In the present report, we describe a second mutation in FGF23 underlying a severe case displaying calcifications of cutaneous and numerous extracutaneous tissues. The mutation (M96T) was found to affect a highly conserved methionine residue at position 96 of the protein. These observations illustrate the extent of genetic and phenotypic heterogeneity in HFTC.

Original languageEnglish (US)
Pages (from-to)261-266
Number of pages6
JournalHuman Genetics
Volume118
Issue number2
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Keywords

  • Calcinosis
  • Extraskeletal
  • FGF23
  • GALNT3
  • Mutation
  • Phosphate

Fingerprint Dive into the research topics of 'A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification'. Together they form a unique fingerprint.

Cite this